title: Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen.
abstract: The effects of oral administration of ovalbumin (OVA) on acute OVA-induced arthritis (OIA) in rats, which is mediated by Arthus reaction to the antigen in the joint space, were investigated. The oral administration of OVA before immunization with OVA significantly suppressed the development of acute OIA in a dose-dependent manner, in accordance with decreases in both the in vivo anti-OVA IgG antibody production and in vitro lymphocyte proliferative responses to OVA. These results were shown in both the single high-dose (200 mg x 1) or the multiple low-dose (200 microg x 5) feeding protocols. In vitro study showed that rat IL-2 could reverse the reduced OVA-specific lymphocyte proliferative responses. The spleen cells obtained from OVA-feeding, unprimed rats neither adoptively transferred the suppression to naive recipient rats nor suppressed the in vitro lymphocyte proliferation. These results demonstrate that the acute OIA can be suppressed by the induction of oral tolerance (OT) to OVA, and strongly suggest that the OT was due to clonal anergy of antigen-reactive T lymphocytes, not the active suppression by OVA-specific regulatory cells.
authors.affiliation: Department of Microbiology, Saga Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Inada
authors.forename: S
authors.initials: S
authors.lastname: Yoshino
authors.forename: M A
authors.initials: MA
authors.lastname: Haque
authors.forename: Y
authors.initials: Y
authors.lastname: Ogata
authors.forename: O
authors.initials: O
authors.lastname: Kohashi
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D019264:Adoptive Transfer; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D001168:Arthritis / Q000209:etiology / Q000276:immunology* / Q000517:prevention & control*; D017635:Clonal Anergy; D005260:Female; D007114:Immunization; D007074:Immunoglobulin G / Q000096:biosynthesis; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation; D008297:Male; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D051381:Rats; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000941:Antigens; D007074:Immunoglobulin G; D007376:Interleukin-2; D010047:Ovalbumin